HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"

HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy.* The results show significant ...
European Medical Journal

Nurse-Led Bladder Guidance Improves Radiotherapy Precision

Nurse-led bladder volume support improved radiotherapy reproducibility and reduced repeat imaging in prostate cancer. Read ...